Adenovirus-mediated hPNPaseold-35 gene transfer as a therapeutic strategy for neuroblastoma

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 707-715

  Van Maerken, Tom ^a,b,c   Sarkar, Devanand ^a,b   Speleman, Frank ^c   Dent, Paul ^a,b   Weiss, William A ^d   Fisher, Paul B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERASE; CAR RECEPTOR; EXORIBONUCLEASE; KRUPPEL LIKE FACTOR; PEG3 PROTEIN, HUMAN; PNPT1 PROTEIN, HUMAN; RECOMBINANT PROTEIN; VIRUS RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; MELANOCYTE; NEURAL CREST; NEUROBLASTOMA CELL; PEG 3; PRIORITY JOURNAL; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENE; ADENOVIRUS; CELL DIVISION; CELL LINE; CELL PROLIFERATION; CYTOLOGY; ENZYMOLOGY; GENE THERAPY; GENE VECTOR; GENETICS; MALE; METHODOLOGY; NEUROBLASTOMA; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOVIRIDAE; CYTOMEGALOVIRUS;

ADENOVIRIDAE; APOPTOSIS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; EXORIBONUCLEASES; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MELANOCYTES; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, VIRUS; RECOMBINANT PROTEINS;

EID: 64549142407     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21719     Document Type: Article

References (38)

1. Ardelt B, Ardelt W, Darzynkiewicz Z. 2003. Cytotoxic ribonucleases and RNA interference (RNAi). Cell Cycle 2:22-24.
2. Arnold U, Ulbrich-Hofmann R. 2006. Natural and engineered ribonucleases as potential cancer therapeutics. Biotechnol Lett 28:1615-1622. (Pubitemid 44369323)
3. Beck AK, Pass HI, Carbone M, Yang H. 2008. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncol 4:341-349.
4. Benito A, Ribo M, Vilanova M. 2005. On the track of antitumour ribonucleases. Mol Biosyst 1:294-302. (Pubitemid 41579320)
5. Brodeur GM. 2003. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3:203-216. (Pubitemid 37328872)
6. old-35)-mediated growth suppression. J Cell Physiol 215:401-409.
7. Cinatl J Jr., Cinatl J, Kotchetkov R, Vogel JU, Woodcock BG, Matousek J, Pouckova P, Kornhuber B. 1999. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis. Int J Oncol 15:1001-1009.
8. Cinatl J Jr., Cinatl J, Kotchetkov R, Matousek J, Woodcock BG, Koehl U, Vogel JU, Kornhuber B, Schwabe D. 2000. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs. Anticancer Res 20:853-859. (Pubitemid 30240645)
9. D'Alessio G. 1993. New and cryptic biological messages from RNases. Trends Cell Biol 3:106-109. (Pubitemid 23098848)
10. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19.
11. Holmes M, Rosenberg E, Valerie K. 2003. Adenovirus expressing p53. Methods Mol Biol 234:1-16.
12. Jasty R, Lu J, Irwin T, Suchard S, Clarke MF, Castle VP. 1998. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells. Mol Genet Metab 65:155-164. (Pubitemid 28507136)
13. Kotchetkov R, Cinatl J, Matousek J, Vogel J, Pouckova P, Wagner M, Kornhuber B, Schwabe D, Cinatl J Jr. 2000. Bovine seminal ribonuclease inhibits in vivo growth of human neuroblastoma cells. Oncol Rep 7:363-367.
14. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. 2002. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21:708-718. (Pubitemid 34146283)
15. Lebedeva IV, Sarkar D, Su ZZ, Kitada S, Dent P, Stein CA, Reed JC, Fisher PB. 2003. Bcl-2 and Bcl-xL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 22:8758-8773. (Pubitemid 38010500)
16. old-35, in the context of terminal differentiation and cellular senescence. Proc Natl Acad Sci U S A 99:16636-16641.
17. old-35, a Type I interferon inducible early response gene. Gene 316:143-156.
18. Maris JM, Hogarty MD, Bagatell R, Cohn SL. 2007. Neuroblastoma. Lancet 369:2106-2120.
19. McConville CM, Forsyth J. 2003. Neuroblastoma - a developmental perspective. Cancer Lett 197:3-9. (Pubitemid 36859983)
20. Michaelis M, Cinatl J, Anand P, Rothweiler F, Kotchetkov R, Deimling A, Doerr HW, Shogen K, Cinatl J Jr. 2007. Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells. Cancer Lett 250:107-116. (Pubitemid 46483847)
21. Pattyn F, Speleman F, De Paepe A, Vandesompele J. 2003. RTPrimerDB: The real-time PCR primer and probe database. Nucleic Acids Res 31:122-123. (Pubitemid 36150349)
22. Pattyn F, Robbrecht P, De Paepe A, Speleman F, Vandesompele J. 2006. RTPrimerDB: The real-time PCR primer and probe database, major update2006. Nucleic Acids Res 34:D684-D688.
23. Ross RA, Spengler BA. 2007. Human neuroblastoma stem cells. Semin Cancer Biol 17:241-247. (Pubitemid 46413078)
24. Sarkar D, Fisher PB. 2006. Polynucleotide phosphorylase: An evolutionary conserved gene with an expanding repertoire of functions. Pharmacol Ther 112:243-263. (Pubitemid 44301489)
25. old-35) in human melanoma cells. J Biol Chem 278:24542-24551.
26. old-35): A potential link between aging and inflammation. Cancer Res 64:7473-7478.
27. OLD-35) mediating cellular senescence. Mol Cell Biol 25:7333-7343.
28. Sarkar D, Park ES, Fisher PB. 2006. Defining the mechanism by which IFN-β downregulates c-myc expression in human melanoma cells: Pivotal role for human polynucleotide phosphorylase (hPNPaseold-35). Cell Death Differ 13:1541-1553. (Pubitemid 44210357)
29. old-35) induces apoptosis. Cancer Res 67:7948-7953.
30. Su ZZ, Sarkar D, Emdad L, Duigou GJ, Young CS, Ware J, Randolph A, Valerie K, Fisher PB. 2005. Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter. Proc Natl Acad Sci U S A 102:1059-1064. (Pubitemid 40170725)
31. Tweddle DA, Malcolm AJ, Cole M, Pearson AD, Lunec J. 2001. p53 cellular localization and function in neuroblastoma: Evidence for defective G1 arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol 158:2067-2077. (Pubitemid 32545192)
32. Van Maerken T, Speleman F, Vermeulen J, Lambertz I, De Clercq S, De Smet E, Yigit N, Coppens V, Philippe J, De Paepe A, Marine JC, Vandesompele J. 2006. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma. Cancer Res 66:9646-9655. (Pubitemid 44623664)
33. Vandesompele J, De Paepe A, Speleman F. 2002a. Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal Biochem 303:95-98. (Pubitemid 34271110)
34. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002b. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:research 0034.1-research 0034.11.
35. Vasandani VM, Wu YN, Mikulski SM, Youle RJ, Sung C. 1996. Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily. Cancer Res 56:4180-4186. (Pubitemid 26305013)
36. Vasandani VM, Burris JA, Sung C. 1999. Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptake. Cancer Chemother Pharmacol 44:164-169. (Pubitemid 29297064)
37. Youle RJ, Newton D, Wu YN, Gadina M, Rybak SM. 1993. Cytotoxic ribonucleases and chimeras in cancer therapy. Crit Rev Ther Drug Carrier Syst 10:1-28. (Pubitemid 23107931)
38. Young IT. 1977. Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935-941. (Pubitemid 8170725)